Biotechnology Pomerantz Law Firm Announces the Filing of a Class Action Against FibroGen, Inc. and Certain Officers – FGEN May 1, 2021
Tech Deadline Reminder: Kessler Topaz Meltzer & Checker, LLP Reminds Investors of Leidos Holdings, Inc. of Lead Plaintiff Deadline in Securities Fraud Class Action Lawsuit May 1, 2021
Biotechnology FibroGen, Inc. Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against FibroGen, Inc. May 1, 2021
Press Release Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline for Securities Fraud Class Action Lawsuit Filed Against Pinterest, Inc. May 1, 2021
Health Class Action Reminder: Labaton Sucharow LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc. (NYSE:EBS) May 1, 2021
Biotechnology Denali Therapeutics Presents Positive Results from Phase 1 and Phase 1b Studies of Its LRRK2 Inhibitor, BIIB122/DNL151, Supporting Late-Stage Development Plans in Parkinson’s Disease May 1, 2021
Press Release SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Pinterest, Inc. and Encourages Investors with Losses to Contact the Firm May 1, 2021
Biotechnology Editas Medicine to Present Preclinical Data Demonstrating Advancements in In Vivo Gene Editing Approach for the Treatment of Genetic Ocular Diseases at the Association for Research in Vision and Ophthalmology Annual Meeting May 1, 2021